XML 12 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Statements of Income - USD ($)
12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Revenue      
Product sales $ 26,182,453 $ 24,410,391 $ 29,894,045
Contract research and development 2,143,743 3,306,887 690,043
Total revenue 28,326,196 27,717,278 30,584,088
Cost of sales 6,078,294 6,616,852 6,019,868
Gross profit 22,247,902 21,100,426 24,564,220
Expenses      
Selling, general, and administrative 1,458,598 1,752,962 2,312,076
Research and development 3,344,101 3,061,184 3,000,193
Total expenses 4,802,699 4,814,146 5,312,269
Income from operations 17,445,203 16,286,280 19,251,951
Interest income 1,650,808 1,890,817 2,187,723
Income before taxes 19,096,011 18,177,097 21,439,674
Provision for income taxes 6,147,142 5,884,782 7,071,320
Net income $ 12,948,869 $ 12,292,315 $ 14,368,354
Net income per share – basic (in dollars per share) $ 2.68 $ 2.53 $ 2.96
Net income per share – diluted (in dollars per share) 2.68 2.53 2.95
Common Stock, Dividends, Per Share, Declared $ 4 $ 4 $ 2.06
Weighted average shares outstanding      
Basic (in shares) 4,836,602 4,850,209 4,855,504
Diluted (in shares) 4,838,389 4,852,602 4,871,935